Clinical Trial Update: Retrospective Multicenter Real-world Observational Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration

View source ↗

Summary

A multicenter, real-world retrospective observational study is planned to assess switching patients with refractory or dependent exudative age-related macular d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Aflibercept 8 mg (aflibercept)

Snippet

Sponsor: Nantes University Hospital | Conditions: Exudative Age-Related Macular Degeneration | Status: NOT_YET_RECRUITING